Early breast cancer guideline update
From Session 3, ‘Integrating CDK4/6 inhibitors into clinical practice for early breast cancer’, Dr Gregory Vidal summarises updates to early breast cancer clinical practice guidelines.
This site is intended for healthcare professionals
